RAD18 | RAD18 homolog (S. cerevisiae) | Plasma proteins
| | | | | Mixed |
TMEM40 | Transmembrane protein 40 | Predicted membrane proteins
| | | | | Group enriched |
XPC | Xeroderma pigmentosum, complementation group C | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
TOP2B | Topoisomerase (DNA) II beta 180kDa | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
OXSM | 3-oxoacyl-ACP synthase, mitochondrial | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
UQCRC1 | Ubiquinol-cytochrome c reductase core protein I | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APEH | Acylaminoacyl-peptide hydrolase | Enzymes Plasma proteins
| | | | | Expressed in all |
TMEM115 | Transmembrane protein 115 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MANF | Mesencephalic astrocyte-derived neurotrophic factor | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
PRKCD | Protein kinase C, delta | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
TKT | Transketolase | Enzymes Plasma proteins
| | | | | Expressed in all |
FLNB | Filamin B, beta | Disease related genes Plasma proteins
| | | | | Expressed in all |
ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | Predicted membrane proteins
| | | | | Expressed in all |
MITF | Microphthalmia-associated transcription factor | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FOXP1 | Forkhead box P1 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
GBE1 | Glucan (1,4-alpha-), branching enzyme 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
TOMM70A | Translocase of outer mitochondrial membrane 70 homolog A (S. cerevisiae) | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
GAP43 | Growth associated protein 43 | Plasma proteins Transporters
| | | | | Tissue enriched |
POGLUT1 | Protein O-glucosyltransferase 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
GTF2E1 | General transcription factor IIE, polypeptide 1, alpha 56kDa | Plasma proteins
| | | | | Expressed in all |
HCLS1 | Hematopoietic cell-specific Lyn substrate 1 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
PDIA5 | Protein disulfide isomerase family A, member 5 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
MCM2 | Minichromosome maintenance complex component 2 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
RAB7A | RAB7A, member RAS oncogene family | Disease related genes Plasma proteins
| | | | | Expressed in all |
CDV3 | CDV3 homolog (mouse) | Plasma proteins
| | | | | Expressed in all |
MRPS22 | Mitochondrial ribosomal protein S22 | Disease related genes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
COPB2 | Coatomer protein complex, subunit beta 2 (beta prime) | Plasma proteins
| | | | | Expressed in all |
RBP1 | Retinol binding protein 1, cellular | | | | | | Tissue enhanced |
WWTR1 | WW domain containing transcription regulator 1 | Cancer-related genes
| | | | | Mixed |
PFN2 | Profilin 2 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SSR3 | Signal sequence receptor, gamma (translocon-associated protein gamma) | Predicted membrane proteins
| | | | | Expressed in all |
LXN | Latexin | | | | | | Expressed in all |
SMC4 | Structural maintenance of chromosomes 4 | Plasma proteins
| | | | | Expressed in all |
PDCD10 | Programmed cell death 10 | Disease related genes
| | | | | Expressed in all |
PSMD2 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 | FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
POLR2H | Polymerase (RNA) II (DNA directed) polypeptide H | RNA polymerase related proteins
| | | | | Expressed in all |
TRA2B | Transformer 2 beta homolog (Drosophila) | Plasma proteins
| | | | | Expressed in all |
DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | Predicted secreted proteins
| | | | | Expressed in all |
AHSG | Alpha-2-HS-glycoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
RFC4 | Replication factor C (activator 1) 4, 37kDa | Plasma proteins
| | | | | Expressed in all |
LPP | LIM domain containing preferred translocation partner in lipoma | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NCBP2 | Nuclear cap binding protein subunit 2, 20kDa | Transporters
| | | | | Expressed in all |